- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Achilles Therapeutics Stock (NASDAQ:ACHL), Quotes and News Summary
Achilles Therapeutics Stock (NASDAQ: ACHL)
| Day Range2.25 - 2.52 | 52 Wk Range1.84 - 5.35 | Open / Close2.42 / - | Float / Outstanding39.2M / 40.8M |
| Vol / Avg.11.1K / 38.1K | Mkt Cap93.8M | P/E- | 50d Avg. Price2.9 |
| Div / Yield- | Payout Ratio- | Total Float39.2M | EPS-0.44 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-08 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.560 | -0.440 | 0.1200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Achilles Therapeutics Questions & Answers
You can purchase shares of Achilles Therapeutics (NASDAQ: ACHL) through any online brokerage.
Other companies in Achilles Therapeutics’s space includes: Fortress Biotech (NASDAQ:FBIO), Galectin Therapeutics (NASDAQ:GALT), CytomX Therapeutics (NASDAQ:CTMX), Adverum Biotechnologies (NASDAQ:ADVM) and Inozyme Pharma (NASDAQ:INZY).
The latest price target for Achilles Therapeutics (NASDAQ: ACHL) was reported by JP Morgan on Monday, April 26, 2021. The analyst firm set a price target for 11.00 expecting ACHL to rise to within 12 months (a possible 378.26% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $2.3 last updated Today at September 30, 2022, 6:24 PM UTC.
There are no upcoming dividends for Achilles Therapeutics.
Achilles Therapeutics’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Achilles Therapeutics.
Achilles Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.